Comments
- No comments found
- Urine volume and change in estimated GFR
- Home
-
About ISN
- Membership
- News
- Topics
- Programs
- Regions
- Initiatives
- Publications
-
Education
-
Education Topics
- Pathology Topics
- Acute Kidney Injury
- Anemia, Iron and trace elements
- Chronic Kidney Disease
- Diabetes
- Fluid and Electrolytes
- General Nephrology
- Global Nephrology
- Glomerular Disease
- Hemodialysis
- Hypertension
- Infections
- Interventional Nephrology
- Mineral and bone disorders
- Nutrition and Hydration
- Peritoneal Dialysis
- Systemic Disease
- Transplantation
- Research Methodology
- Urolithiasis
- Basic Science
-
Education Topics
- Events
Friday, 18 April 2014 15:57
Patients, Research and Drugs audioicon
By Fiona LoudThis presentation was given by Fiona Loud, co-author of ‘Kidney Health: Delivering Excellence’ and Policy Director at the British Kidney Patient Association. It was given during the ISN Nexus Symposium 2014 held in Bergamo, Italy on April 3-6, 2014. The focus this year was on the New era of drug discovery and clinical trials in kidney disease.
Additional Info
- Language: English
- Contains Audio: Yes
- Content Type: Presentations
- Source: ISN
- Event: Nexus
- Year: 2014
- Members Only: No
Read 993 times
Published in
Basic Science
Tagged under
Download attachments:
- Download this presentation (436 Downloads)
Related items
- Drug discovery in kidney disease: from serendipity to rationality
- Fellow: Kamonwan Tangvoraphonkchai From Thailand
- RESULTS OF ARTS-DN: A RANDOMIZED STUDY TO ASSESS THE SAFETY AND EFFICACY OF FINERENONE IN PATIENTS WITH TYPE 2 DIABETES AND DIABETIC NEPHROPATHY
- Interaction between academia, industry and government audioicon
- What have we learned from animal models of diabetic Nephropathy?
|
Global Operations Center Rue des Fabriques 1 |
Americas Operations Center 340 North Avenue 3rd Floor |
Administrator Login
Leave your comments
Post comment as a guest